Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05534100 · ClinicalTrials.gov registry record
Using Wearable Technology to Detect Symptoms of Posttraumatic Stress Disorder
A clinical trial, sponsored by Rush University Medical Center.
- Terminated
- Registry status
- 14
- Enrollment target
NCT05534100: Clinical Trial study, sponsored by Rush University Medical Center.
NCT05534100 is a clinical trial that was terminated before completion, run by Rush University Medical Center. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05534100 was terminated before completion, sponsored by Rush University Medical Center.
- TERMINATED
- Registry status
- 14 participants
- Enrollment target
Study Summary
The aim of the project is to advance our understanding of how individuals with Posttraumatic Stress Disorder (PTSD) experience symptoms in their every-day lives when they are in their home environment. To date, all PTSD assessments are retrospective; individuals with PTSD are asked to recount and report their symptoms over the past weeks or months. Such assessment procedures are negatively impacted by individuals' abilities to accurately recall information. Moreover, retrospective assessments provide little information about how symptoms are experienced in the moment and how these experiences then lead to other behaviors. The proposed project addresses these limitations by assessing PTSD symptoms and associated biological markers (e.g., sleep, heart rate, heart rate variability) in real-time by asking subjects to wear a smart device and complete brief surveys. Data will be collected from 50 individuals with PTSD and 20 healthy controls to help us better understand individuals' real-time experience with PTSD and lay the foundation to develop algorithms for possible in-the-moment interventions in the future.
Primary Outcome
Clinician administered measure of PTSD
Interventions
- DEVICE Biostrap EVO Wristband
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2023-09-01 |
Why NCT05534100 stopped before completion
NCT05534100 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Biostrap EVO Wristband is the first listed.
NCT05534100 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05534100 about?
NCT05534100 is a clinical study titled "Using Wearable Technology to Detect Symptoms of Posttraumatic Stress Disorder". The aim of the project is to advance our understanding of how individuals with Posttraumatic Stress Disorder (PTSD) experience symptoms in their every-day lives when they are in their home environment. To date, all PTSD assessments are retrospective; individuals with PTSD are asked to recount and re...
What is the current status of trial NCT05534100?
This trial is currently terminated. The enrollment target is 14 participants. The study started on 2022-11-01. Estimated completion is 2023-09-01.
What interventions are being tested in trial NCT05534100?
The interventions under investigation include: Biostrap EVO Wristband (DEVICE).
Who is sponsoring clinical trial NCT05534100?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy